Brief: Amneal Launches Crexont® (Carbidopa And Levodopa) Extended-Release Capsules For Treatment Of Parkinson’S Disease
23/09/2024 14:28
Sept 23 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O :
* AMNEAL LAUNCHES CREXONT® (CARBIDOPA AND LEVODOPA)
EXTENDED-RELEASE CAPSULES FOR TREATMENT OF PARKINSON’S DISEASE
* AMNEAL PHARMACEUTICALS INC - CREXONT NOW AVAILABLE AT U.S.
PHARMACIES
* AMNEAL PHARMACEUTICALS INC - ELIGIBLE PATIENTS MAY QUALIFY
FOR
$25 COPAY THROUGH CREXONT SAVINGS PROGRAM
Source text for Eikon: ID:nBwpYSVHa
Further company coverage: AMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study